Page last updated: 2024-10-20

pteridines and Hypoxia-Ischemia, Brain

pteridines has been researched along with Hypoxia-Ischemia, Brain in 1 studies

Hypoxia-Ischemia, Brain: A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.

Research Excerpts

ExcerptRelevanceReference
" The key findings leading to diagnosis were neonatal seizures unresponsive to treatment, craniofacial dysmorphic features, hyperexcitability, low blood uric acid levels, and neuroimaging findings."3.71Molybdenum cofactor deficiency: report of three cases presenting as hypoxic-ischemic encephalopathy. ( Coskun, T; Haliloglu, G; Saatci, I; Topcu, M, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topcu, M1
Coskun, T1
Haliloglu, G1
Saatci, I1

Other Studies

1 other study available for pteridines and Hypoxia-Ischemia, Brain

ArticleYear
Molybdenum cofactor deficiency: report of three cases presenting as hypoxic-ischemic encephalopathy.
    Journal of child neurology, 2001, Volume: 16, Issue:4

    Topics: Coenzymes; Diagnosis, Differential; Female; Humans; Hypoxia-Ischemia, Brain; Infant; Infant, Newborn

2001